Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-30

FDA Approved: TROSPIUM CHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Slate Run Pharmaceuticals' original application for trospium chloride, a generic version of the medication indicated for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROSPIUM CHLORIDE

Snippet

ORIG AP for TROSPIUM CHLORIDE (TROSPIUM CHLORIDE)